We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01543698
Recruitment Status : Active, not recruiting
First Posted : March 5, 2012
Last Update Posted : February 23, 2018
Information provided by (Responsible Party):
Array BioPharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : September 14, 2017
  Estimated Study Completion Date : December 31, 2018